NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered BPC-157 from HXNet? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
67%
Finnrick rating
#5 of 149 BPC-157 vendors
9 of 10 classifiable tests passed
natural 90% · customers 4.7★ (5)
methodology · Purity focus
Finnrick analysis · BPC-157

HXNet BPC-157 is pulled down mainly by one early vial testing +70% overfilled; later identity and purity results stayed clean with tighter fills, while older no-label and batch gaps limit documentation confidence.

methodology →
vendor intelligence report
Vendor Intelligence Report: HXNet

Chinese registry snippets show the ChemicalBook anchor entity was cancelled before the current sales run. The report maps the HXTNT/LaraPharma channel shift, lookalike web infrastructure, and COA files that reuse third-party lab identifiers.

41 pages5 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.04
90%
14
2
Tirzepatide
$0.35
89%
52
3
Retatrutide
$0.60
83%
49
4
Semaglutide
$1.00
76%
5
6
BPC-157selected
$0.60
67%
10
7
PT-141
$0.50
64%
2
8
Cagrilintide
$1.76
62%
15
9
Tesamorelin
$1.80
54%
12
10
CJC-1295
-
49%
5
11
Sermorelin
-
49%
3
12
TB-500
$1.36
48%
6
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%29 Dec 2025: 45%1 Jan 2026: 48%15 Jan 2026: 51%26 Jan 2026: 48%15 Feb 2026: 53%18 Feb 2026: 56%10 Mar 2026: 60%6 Jun 2026: 63%24 Jun 2026: 66%23 Oct 2026: 67%15 Nov 2026: current 67%45%63%67%Dec 25Nov 26
Showing BPC-157 tests only
HXNet BPC-157 test history
COA-backed lab tests

About HXNet test results from Finnrick

HXNet is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 178 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HXNet peptides in this dataset are Tirzepatide (52 tests), Semaglutide (5 tests) and BPC-157 (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 178 recent tests.

Corrections
No corrections.
Peptide testing

Ordered BPC-157 from HXNet? Mail in a sample (US only) and let us test it.

Test my supply